Crescent Biopharma, Inc. Common Stock (CBIO)
Across 17 earnings reports since Aug 05, 2021, Crescent Biopharma, Inc. Common Stock (CBIO) has a clear post-earnings pattern. It moves ±6.61% on average after reporting and finishes higher 52.9% of the time. Its largest post-earnings gain was +22.02% (Nov 09, 2022) and its largest decline was -12.99% (Mar 03, 2022).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±6.61%
Positive %
52.9%
Negative %
47.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | ☽ POST | $23.58 | $23.75 | $20.78 | 9,287 | +7.34% | open_in_new |
| Feb 26, 2026 | ☀ PRE | $12.06 | $12.60 | $12.34 | 1,986 | -1.4% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $12.77 | $13.10 | $13.04 | 3,480 | +4.7% | open_in_new |
| Jul 31, 2025 | ☀ PRE | $12.39 | $12.61 | $12.44 | 856 | -0.92% | open_in_new |
| Jun 18, 2025 | ☽ POST | $12.85 | $14.32 | $14.10 | 308 | +8.37% | open_in_new |
| May 06, 2024 | ☽ POST | $0.35 | $0.41 | $0.31 | 786,416 | -2.83% | open_in_new |
| Mar 27, 2024 | ☀ PRE | $2.95 | $3.18 | $3.18 | 29,985 | +11.38% | open_in_new |
| Nov 03, 2023 | ☀ PRE | $1.36 | $1.36 | $1.34 | 1,170 | +3.88% | open_in_new |
| Aug 02, 2023 | ☀ PRE | $1.60 | $1.61 | $1.61 | 1,168 | -2.72% | open_in_new |
| May 03, 2023 | ☀ PRE | $1.37 | $1.42 | $1.37 | 3,410 | -1.44% | open_in_new |
| Mar 29, 2023 | ☀ PRE | $1.23 | $1.28 | $1.25 | 3,009 | -10.71% | open_in_new |
| Nov 09, 2022 | ☀ PRE | $0.71 | $0.82 | $0.82 | 818 | +22.02% | open_in_new |
| Aug 03, 2022 | ☀ PRE | $0.70 | $0.70 | $0.70 | 836 | +2.32% | open_in_new |
| Apr 28, 2022 | ☀ PRE | $0.83 | $0.83 | $0.77 | 2,232 | -8.07% | open_in_new |
| Mar 03, 2022 | ☀ PRE | $1.22 | $1.22 | $1.10 | 525 | -12.99% | open_in_new |
| Nov 02, 2021 | ☀ PRE | $1.97 | $2.05 | $2.05 | 2,835 | +3.27% | open_in_new |
| Aug 05, 2021 | ☀ PRE | $1.97 | $2.15 | $2.15 | 4,347 | +8.04% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±6.61%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
8 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
Frequently asked about CBIO earnings
How much does CBIO stock move after earnings? expand_more
Over 17 reports, CBIO has moved an average of ±6.61% the session after earnings, closing higher 52.9% of the time.
What was CBIO's biggest post-earnings move? expand_more
CBIO's largest post-earnings gain on record was +22.02% on Nov 09, 2022, and its largest decline was -12.99% on Mar 03, 2022.
Where can I find Crescent Biopharma, Inc. Common Stock's SEC filings? expand_more
All of Crescent Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right